๐
Glybera
alipogene tiparvovec
Hyperlipoproteinemia Type I
โน๏ธ Expired
Advanced therapy
โ
No active alerts
This medicine has no ongoing shortages, safety letters or recalls.
What it's used for
Glybera is indicated for adult patients diagnosed with familial lipoprotein lipase deficiency (LPLD) and suffering from severe or multiple pancreatitis attacks despite dietary fat restrictions. The diagnosis of LPLD has to be confirmed by genetic testing. The indication is restricted to patients with detectable levels of LPL protein.
โ ๏ธ Patient safety
No
Official EMA page
https://www.ema.europa.eu/en/medicines/human/EPAR/glybera